These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Tardive dyskinesia: behavioral effects of repeated intracerebroventricular haloperidol injections in rats do not confirm the kindling hypothesis. Andreassen OA; Jørgensen HA Pharmacol Biochem Behav; 1994 Oct; 49(2):309-12. PubMed ID: 7824543 [TBL] [Abstract][Full Text] [Related]
28. Effects of withdrawal from long-term barbital treatment on open-field behaviour and seizure susceptibility of rats. Palermo-Neto J; De Lima TC Neuropharmacology; 1982 Mar; 21(3):277-81. PubMed ID: 6122187 [TBL] [Abstract][Full Text] [Related]
29. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat. Pittman KJ; Jakubovic A; Fibiger HC Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831 [TBL] [Abstract][Full Text] [Related]
30. The interaction between beta-[Tyr9]melanotropin-(9-18), haloperidol and amphetamine in different behavior tests of rats. Telegdy G; Vécsei L; Schally AV; Coy DH Pharmacol Biochem Behav; 1982 Jul; 17(1):15-8. PubMed ID: 7122660 [TBL] [Abstract][Full Text] [Related]
31. Spontaneous activity and apomorphine stereotypy during and after withdrawal from 3 1/2 months continuous administration of haloperidol: some methodological issues. Waddington JL; Gamble SJ Psychopharmacology (Berl); 1980; 71(1):75-7. PubMed ID: 6779327 [TBL] [Abstract][Full Text] [Related]
32. Voluntary oral morphine self-administration in rats: effect of haloperidol or ondansetron. Borg PJ; Taylor DA Pharmacol Biochem Behav; 1994 Mar; 47(3):633-46. PubMed ID: 8208784 [TBL] [Abstract][Full Text] [Related]
33. Effect of haloperidol withdrawal on motor activity and circadian rhythm of rats. Kumar A; Chandra O; Saxena PN Arzneimittelforschung; 1981; 31(7):1096-8. PubMed ID: 7196758 [TBL] [Abstract][Full Text] [Related]
34. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity. De Veaugh-Geiss J; Devanand DP; Carey RJ Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268 [TBL] [Abstract][Full Text] [Related]
35. Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats. Neisewander JL; Lucki I; McGonigle P Pharmacol Biochem Behav; 1996 Apr; 53(4):935-42. PubMed ID: 8801600 [TBL] [Abstract][Full Text] [Related]
36. The attenuation of delta 9-tetrahydrocannabinol and morphine of the quasi-morphine withdrawal syndrome in rats. Zaluzny SG; Chesher GB; Jackson DM; Malor R Psychopharmacology (Berl); 1979 Mar; 61(2):207-16. PubMed ID: 86997 [TBL] [Abstract][Full Text] [Related]
37. Haloperidol ameliorates androgen-induced behavioral deficits in developing male rats. Qi C; Ji X; Zhang G; Kang Y; Huang Y; Cui R; Li S; Cui H; Shi G J Endocrinol; 2018 May; 237(2):193-205. PubMed ID: 29563235 [TBL] [Abstract][Full Text] [Related]
38. Behavioral supersensitivity to beta-phenylethylamine after chronic administration of haloperidol. Stoff DM; Jeste DV; Gillin JC; Moja EA; Cohen L; Stauderman KA; Wyatt RJ Biol Psychiatry; 1984 Jan; 19(1):101-6. PubMed ID: 6538440 [No Abstract] [Full Text] [Related]
39. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum. Meller E; Friedman E Eur J Pharmacol; 1981 Nov; 76(1):25-9. PubMed ID: 7318921 [TBL] [Abstract][Full Text] [Related]